Amarin Corp Plcuk (AMRN) Total Debt (2011 - 2020)
Amarin Corp Plcuk (AMRN) posted quarterly Total Debt of $9.5 million for Q3 2020, down 84.23% YoY from $60.0 million in Q4 2019, and down 57.84% sequentially from $22.5 million in Q2 2020.
Amarin Corp Plcuk (AMRN) Total Debt (2011 - 2020) Analysis & Trends
Amarin Corp Plcuk has disclosed Total Debt across 11 years of filings, most recently posting $9.5 million for Q3 2020.
- In Q3 2020, Total Debt fell 84.23% year-over-year to $9.5 million; the TTM figure through Sep 2020 stood at $9.5 million (down 84.23% YoY), while the FY2019 annual figure was $50.1 million, down 37.61% from the prior year.
- Total Debt eased to $9.5 million in Q3 2020, from $22.5 million in the prior quarter.
- Over the last five years, Total Debt for AMRN reached as high as $156.5 million in Q2 2016 and fell as low as $9.5 million in Q3 2020.
- The 5-year median for Total Debt is $53.4 million (2018), against an average of $60.5 million.
- Annual changes were most pronounced in 2016 — Total Debt slumped 87.17% — and 2019, when it soared 131.92%.
- A 5-year view of Total Debt shows it stood at $100.5 million in 2016, then plunged by 48.92% to $51.3 million in 2017, then soared by 56.5% to $80.3 million in 2018, then tumbled by 37.61% to $50.1 million in 2019, then slumped by 81.12% to $9.5 million in 2020.
- According to Business Quant data, Total Debt over the past three periods registered $9.5 million, $22.5 million, and $37.0 million for Q3 2020, Q2 2020, and Q1 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 43.37 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 54.99 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 64.53 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -24.45 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 49.12 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 57.32 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 22.17 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 64.46 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -19.00 Mn |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 9.47 Mn |
| Jun 30, 2020 | 22.46 Mn |
| Mar 31, 2020 | 36.98 Mn |
| Dec 31, 2019 | 50.13 Mn |
| Sep 30, 2019 | 60.04 Mn |
| Jun 30, 2019 | 68.61 Mn |
| Mar 31, 2019 | 74.30 Mn |
| Dec 31, 2018 | 80.35 Mn |
| Sep 30, 2018 | 29.38 Mn |
| Jun 30, 2018 | 29.58 Mn |
| Mar 31, 2018 | 53.42 Mn |
| Dec 31, 2017 | 51.34 Mn |
| Sep 30, 2017 | 29.16 Mn |
| Jun 30, 2017 | 79.74 Mn |
| Mar 31, 2017 | 99.41 Mn |
| Dec 31, 2016 | 100.51 Mn |
| Sep 30, 2016 | 13.47 Mn |
| Jun 30, 2016 | 156.46 Mn |
| Mar 31, 2016 | 104.74 Mn |
| Dec 31, 2015 | 149.21 Mn |